Do you want to read an article? Please log in or register.
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
Pulmonary Fibrosis
Related content
Interstitial Lung DiseasePulmonary Fibrosis
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial
Am J Respir Crit Care Med
Maher TM, Hamblin MJ, Choi WI, Case AH, Tomos IP, Tzouvelekis AE, Shore JE, Bergna MA, Golod D, Elenko E, Zhang Y, Graham CS, Song JW, Kulkarni T, ELEVATE IPF Investigators (listed in Supplementary Appendix)
doi: 10.1093/ajrccm/aamag155
RECOMMENDED
Pulmonary Fibrosis
Nerandomilast in idiopathic pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-IPF trial
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Am J Respir Crit Care Med
Oldham JM, Azuma A, Kreuter M, Maher TM, Martinez FJ, Richeldi L, Valenzuela C, Wijsenbeek MS, Liu Y, Zisa D, Zoz DF, Cottin V, FIBRONEER-IPF trial investigators
doi: 10.1093/ajrccm/aamag058
RECOMMENDED
Emphysema
Long-term Follow-up Results of Patients with Combined Pulmonary Fibrosis and Emphysema: A Single-Center Experience
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Calis AG, Uzer F, Gurbuz AF, Ozbey G, Cilli A
doi: 10.1016/j.rmed.2026.108780
RECOMMENDED
Emphysema
Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Respirology
Tsubouchi K, Kotetsu Y, Takano T, Ogata H, Kiyomi F, Ichiki K, Takata S, Kitasato Y, Ishii H, Yatera K, Yamasaki K, Okamoto M, Yoshida M, Kawasaki M, Fujita M, Ogawa T, Tobino K, Harada E, Nakagaki N, Komori M, Harada T, Wataya H, Nakanishi Y, Okamoto I
doi: 10.1002/resp.70285
Pulmonary Hypertension
Long-Term Treatment with Single-Tablet Combination of Macitentan and Tadalafil in Pulmonary Arterial Hypertension: Results from A DUE and Its Open-Label Period
Adv Ther
Ford HJ, Chin KM, Fan F, Friberg M, Grünig E, Hauser JA, Pannaux M, Rofael H, Jansa P
doi: 10.1007/s12325-026-03525-3
Pulmonary Fibrosis
Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in children with cystic fibrosis aged 2-5 years (TIMBERLINE Trial VX21-121-105): a phase 3, open-label study
Lancet Respir Med
Rayment JH, Davies G, Gaffin JM, Hoppe JE, Kasi AS, Mall MA, McKone EF, Ramsey B, Taylor JL, Tullis E, McDougall E, Pottackal R, Zahigian R, Krone K, Jennings M, Chmiel JF, 121-105 Study Group
doi: 10.1016/S2213-2600(26)00257-2
RECOMMENDED
Cough
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
Am J Respir Crit Care Med
Hill NS, Gillies H, Chakinala MM, Feldman JP, Hoeper MM, Jing ZC, McLaughlin VV, Rosenkranz S, Escribano-Subias P, Ghio S, Gomberg-Maitland M, Habib N, Kopec G, Langleben D, Lescano A, Ramirez A, Rischard F, Sitbon O, Skride A, Dake BT, Khindri S, Langley J, Niven R, Zhang X, Humbert M, IMPAHCT Investigators
doi: 10.1093/ajrccm/aamaf128
Lung Cancer
Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial
J Thorac Oncol
Baramidze A, Makharadze T, Gogishvili M, Melkadze T, Giorgadze D, Penkov K, Laktionov K, Nemsadze G, Nechaeva M, Rozhkova I, Kalinka E, Li Y, McIntyre DAG, Jia X, Perez J, Kaul M, Lowy I, Pouliot JF, Chua S, Kim E, Seebach F, Magnan H
doi: 10.1016/j.jtho.2026.103980
COMMENTED
Asthma
Safety and efficacy of inhaled itraconazole in adults with asthma and allergic bronchopulmonary aspergillosis (PUR1900-ABPA): a randomized, double-blind, parallel group, placebo-controlled, multicenter, phase 2 trial
★ 3
Recommended and commented by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Agarwal R, Chaudhary D, Gupta SN, Dhar R, Ranganadin P, Kumar R, Mohan A, Bajpai J, Davis R, Sehgal IS, Singh P, Biwas B, Mittal S, Mahendran AJ, Rajan B, Jadhav S, Vaidya A, Chhowala S, Sawant S, Gogtay J
doi: 10.1183/13993003.00058-2026